Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Evonik
Evonik
Activities:
Ingredients
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Graphs and graph data science in drug discovery
Life sciences data expert Dr Alexander Jarasch discusses what work being done at the Institut de Recherches Servier can teach us about using modern data technologies for early...
Why smaller CDMOs should enhance their operational efficiency now: a CPHI expert guide
CPHI experts advise smaller CDMO's to invest in supply chain resilience, friend shoring and AI to keep up with the predicted uptick in funding for 2025
CPI collaborates with industry leaders to expedite drug manufacturing via digitisation
Digitising manufacturing technologies could allow enhanced ability to scale production, reduce costs and expedite the process
Janssen to adopt Johnson & Johnson brand as the company celebrates 100 years of UK operation
The company's pharmaceutical and medical technology segments will combine under the Johnson & Johnson brand name in the UK
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
Drug Delivery
Evonik begins construction on pharmaceutical lipids facility
The centre will be built on the grounds of Evonik Tippecanoe Laboratories and scheduled to go "onstream" in 2025
Infection Control
Evonik launches plant-based squalene to boost vaccine efficacy
It meets the demand for a secure commercial supply of non-animal-derived squalene
Packaging
Evonik wins CPHI Excellence award for "Packaging and Drug Delivery"
The award was presented at the CPHI pharmaceutical trade show in Frankfurt on November 1, 2022
Finance
Evonik introduces three product lines for health care business
This structural shift is aimed to further transitions the health care business line into a system solutions partner for the pharmaceutical and biotech industries
Manufacturing
Evonik invests in 3D printed tablet tech for controlled delivery
Laxxon Medical’s 3D screen printing technology allows tablets to be constructed in layers of API or inert ingredients
Manufacturing
Evonik increases plant-derived cholesterol supply
The ingredient is used in the manufacture of mRNA vaccines and gene therapies
Manufacturing
Evonik launches updated extruder for liposomal drug manufacturing
LIPEX Flow supports the scale-up of processes from drug discovery through to GMP at lab, pilot, intermediate and commercial-scale volumes
Subscribe now